Lv4
520 积分 2022-08-30 加入
ASSESSMENT OF THE EFFICACY OF HYPERGLYCEMIA RISK CLASSIFICATION AND INTRAOPERATIVE GLUCOSE CONTROL PROTOCOL IN ADULT CARDIAC SURGERY PATIENTS
1个月前
已关闭
Long-Term Effectiveness and Safety of Denosumab for Osteoporosis in Patients With Rheumatic Diseases
4个月前
已关闭
A randomized, phase II trial of fulvestrant or exemestane with or without ribociclib after progression on anti-estrogen therapy plus cyclin-dependent kinase 4/6 inhibition (CDK 4/6i) in patients (pts) with unresectable or hormone receptor–positive (HR+), HER2-negative metastatic breast cancer (MBC): MAINTAIN trial
5个月前
已关闭
A randomized, phase II trial of fulvestrant or exemestane with or without ribociclib after progression on anti-estrogen therapy plus cyclin-dependent kinase 4/6 inhibition (CDK 4/6i) in patients (pts) with unresectable or hormone receptor–positive (HR+), HER2-negative metastatic breast cancer (MBC): MAINTAIN trial
5个月前
已关闭
Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial
5个月前
已完结
Elacestrant in ER+, HER2− Metastatic Breast Cancer with ESR1 -Mutated Tumors: Subgroup Analyses from the Phase III EMERALD Trial by Prior Duration of Endocrine Therapy plus CDK4/6 Inhibitor and in Clinical Subgroups
5个月前
已完结
Disitamab Vedotin: First Approval
7个月前
已完结
[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2025 edition)]
7个月前
已完结
Current status and future outlooks on therapeutic drug monitoring of fluorouracil
7个月前
已完结
皖公网安备34019202002308
